Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach
Aim. The aim is to study the correlation between the vaccination rate (VR) and mortality rate of patients with COVID-19 (MpCOV).Methods. The countries with gross domestic product per capita corrected for purchasing power parity (GDP PPP) over $-10,000 were selected for an ecologic study. The city-st...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2022-09-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860043139776512 |
|---|---|
| author | N. A. Benuni A. S. Kotusov F. S. Adzhieva A. E. Kucher K. A. Tolmacheva V. N. Dushuk R. V. Maslennikov |
| author_facet | N. A. Benuni A. S. Kotusov F. S. Adzhieva A. E. Kucher K. A. Tolmacheva V. N. Dushuk R. V. Maslennikov |
| author_sort | N. A. Benuni |
| collection | DOAJ |
| description | Aim. The aim is to study the correlation between the vaccination rate (VR) and mortality rate of patients with COVID-19 (MpCOV).Methods. The countries with gross domestic product per capita corrected for purchasing power parity (GDP PPP) over $-10,000 were selected for an ecologic study. The city-states and countries with a population of 1,000,000 were excluded. The number of patients who died from COVID-19 within a week was divided by the number of patients diagnosed with COVID-19 within a week 20 days earlier to calculate MpCOV.Results. We included 85 countries. VR (r = –0.604; p < 0.001) and GDPpcPPP level (p = 0.202), is an independent determinant of MpCOV. There was no significant difference in MpCOV between groups of countries with VR < 20 % and 20–39 % (1.96 [1.21; 4.67] vs. 1.96 [1.01; 3.36] %; p = 0.464). MpCOV was higher in countries where VR were lower when groups of countries with VR of 20–39 %, 40–59 %, 60–79 %, and ≥80 % were compared (1.96 [1.01; 3.36] vs. 1.11 [0.76; 1.64] vs. 0.50 [0.39; 1.00] vs. 0.16 [0.10; 0.21]; p = 0.003; p = 0.020, and p = 0.008).Conclusions. An increase in VR correlates with a decrease in MpCOV. |
| format | Article |
| id | doaj-art-596f2475c11a4c8e97092729a67afab7 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2022-09-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-596f2475c11a4c8e97092729a67afab72025-02-10T16:14:37ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732022-09-01323232810.22416/1382-4376-2022-32-3-23-28485Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global ApproachN. A. Benuni0A. S. Kotusov1F. S. Adzhieva2A. E. Kucher3K. A. Tolmacheva4V. N. Dushuk5R. V. Maslennikov6Sechenov First Moscow State University (Sechenov University)Sechenov First Moscow State University (Sechenov University)Sechenov First Moscow State University (Sechenov University)Sechenov First Moscow State University (Sechenov University)Sechenov First Moscow State University (Sechenov University); Pirogov Russian National Research Medical UniversitySechenov First Moscow State University (Sechenov University)Sechenov First Moscow State University (Sechenov University); Consultative and diagnostic center № 2 of the Moscow Healthcare DepartmentAim. The aim is to study the correlation between the vaccination rate (VR) and mortality rate of patients with COVID-19 (MpCOV).Methods. The countries with gross domestic product per capita corrected for purchasing power parity (GDP PPP) over $-10,000 were selected for an ecologic study. The city-states and countries with a population of 1,000,000 were excluded. The number of patients who died from COVID-19 within a week was divided by the number of patients diagnosed with COVID-19 within a week 20 days earlier to calculate MpCOV.Results. We included 85 countries. VR (r = –0.604; p < 0.001) and GDPpcPPP level (p = 0.202), is an independent determinant of MpCOV. There was no significant difference in MpCOV between groups of countries with VR < 20 % and 20–39 % (1.96 [1.21; 4.67] vs. 1.96 [1.01; 3.36] %; p = 0.464). MpCOV was higher in countries where VR were lower when groups of countries with VR of 20–39 %, 40–59 %, 60–79 %, and ≥80 % were compared (1.96 [1.01; 3.36] vs. 1.11 [0.76; 1.64] vs. 0.50 [0.39; 1.00] vs. 0.16 [0.10; 0.21]; p = 0.003; p = 0.020, and p = 0.008).Conclusions. An increase in VR correlates with a decrease in MpCOV.https://www.gastro-j.ru/jour/article/view/685vaccinationsars-cov-2covid-19mortalityvaccination rate |
| spellingShingle | N. A. Benuni A. S. Kotusov F. S. Adzhieva A. E. Kucher K. A. Tolmacheva V. N. Dushuk R. V. Maslennikov Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach Российский журнал гастроэнтерологии, гепатологии, колопроктологии vaccination sars-cov-2 covid-19 mortality vaccination rate |
| title | Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach |
| title_full | Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach |
| title_fullStr | Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach |
| title_full_unstemmed | Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach |
| title_short | Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach |
| title_sort | vaccination and mortality of patients with a novel coronavirus infection covid 19 a global approach |
| topic | vaccination sars-cov-2 covid-19 mortality vaccination rate |
| url | https://www.gastro-j.ru/jour/article/view/685 |
| work_keys_str_mv | AT nabenuni vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT askotusov vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT fsadzhieva vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT aekucher vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT katolmacheva vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT vndushuk vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach AT rvmaslennikov vaccinationandmortalityofpatientswithanovelcoronavirusinfectioncovid19aglobalapproach |